Who owns the ECAR trademark?

The ECAR trademark is owned by KSQ Therapeutics, Inc..

What class is the ECAR trademark registered in?

The ECAR trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ECAR?

The USPTO serial number for ECAR is 98590882.

What is the registration number for ECAR?

ECAR is registered under USPTO registration number 0.

Sealvo

Home Search: ECARECAR #98590882

Back

Updated Oct 2, 2026·22 searches this week

View on USPTO TSDR Find similar marks

ECA

USPTO Trademark Record

PENDING

ECAR

SN 98590882·Reg 0·Filed Jun 07, 2024

Owner KSQ Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ECAR (Serial No. 98590882), Registration No. 0, is a pending US trademark filed on Jun 07, 2024 by KSQ Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Conflict Analysis

Full conflict analysis for ECAR (SN 98590882) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

ECAR (Reg. #0) is a pending US trademark that was filed in 2024 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Jun 07, 2024

SERIAL

98590882

REG#

REGISTERED

Dec 31, 1969

Filing Information

StatusPENDING

Filing DateJun 07, 2024

Serial Number98590882

Registration No.0

Registration DateDec 31, 1969

Status DateAug 10, 2026

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1833187

480Dec 09, 2024

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

23 events

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 10, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 10, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 10, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

May 11, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 11, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 11, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 21, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 21, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 21, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Nov 17, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 17, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 17, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 26, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 26, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 26, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Mar 10, 2025

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Mar 10, 2025

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

Dec 27, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 27, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 27, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 17, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 06, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 07, 2024

NEW APPLICATION ENTERED

Other Marks by KSQ Therapeutics, Inc.

Additional USPTO filings from the same owner.

CRI

CRISPROMICS

86888323

KSQ Therapeutics, Inc.

REGISTERED

KSQ

86888308

KSQ Therapeutics, Inc.

REGISTERED

CRI

CRISPR2

88765574

KSQ Therapeutics, Inc.

REGISTERED

ETI

ETIL

88604916

KSQ Therapeutics, Inc.

REGISTERED

Other Marks by Christina M. Licursi

Additional USPTO filings handled by the same attorney of record.

EXP

EXPEDITION

98978174

REGISTERED

TRU

TRUPREP

98178281

REGISTERED

YAL

YALE

74489560

REGISTERED

A2B

86454366

REGISTERED

ECAR

Run a conflict check

Other Marks by KSQ Therapeutics, Inc.

Other Marks by Christina M. Licursi

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company